维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Gimson C"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure显示文摘	O'GRADY J GIMSON A O'BRIEN C	1988	Gastroenterology1988，94，51：	1
	2	The effects of manufacturing methods on the precision of insertion and in-line thermal mass flowmeters显示文摘	Baker-Roger C Gimson C	2001	Flow Measurement and Instrumentation2001，12，2：	1
	3	Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure显示文摘	Canalese J Gimson AE Davis C		0，，07：	1
	4	controlled trails of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure显示文摘	0' Grady J G Gimson A E 0' Brein C J	2002	Gastroenterology2002，94，：	1
	5	Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure显示文摘	Canalese J Gimson AE Davis C	1982	Gut1982，，07：	1
	6	Sirolimus: a potent new immunosuppressant for liver transplantation显示文摘	Watson C J Friend P J Jamieson N V Frick T W Alexander G Gimson A E	1999	Transplantation1999，67，：	1
	7	Assessment of the percutaneous endoscopic gastrostomy feeding tube as part of an integrated approach to enteral feeding 显示文摘	Wicks C Gimson A Vlavianos P	1992	Gut1992，33，5：	1
	8	Arandomized controlled trial of late cinverson from calcincurin inhibitor(CNl)-base to sirplimus-base immunosuppression in liver transplant recipients with impaired renal function显示文摘	Watson CJ Gimson A E Alexander G J Allison M E Gibbs P Smith J C		0，，：	1
	9	Sirolimus: a potent new immunosuppressant for liver transplantation 显示文摘	Watson C J Friend P J J amieson N V Frick T W Alexander G Gimson A E	1999	Transplantation1999，67，：	1
	10	A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function显示文摘	Watson C J Gimson A E Alexander G J Allison M E Gibbs P Smith J C	2007	Liver Transpl2007，13，：	1
	11	Time spent in hospital after liver transplantation:Effects of primary liver disease and comorbidity显示文摘AIM To explore the effect of primary liver disease and comorbidities on transplant length of stay(TLOS) and LOS in later admissions in the first two years after liver transplantation(LLOS). METHODS A linked United Kingdom Liver Transplant Audit- Hospital Episode Statistics database of patients who received a first adult liver transplant between 1997 and 2010 in Englandwas analysed. Patients who died within the first two years were excluded from the primary analysis, but a sensitivity analysis was also performed including all patients. Multivariable linear regression was used to evaluate the impact of primary liver disease and comorbidities on TLOS and LLOS. RESULTS In 3772 patients, the mean(95%CI) TLOS was 24.8(24.2 to 25.5) d, and the mean LLOS was 24.2(22.9 to 25.5) d. Compared to patients with cancer, we found that the largest difference in TLOS was seen for acute hepatic failure group(6.1 d; 2.8 to 9.4) and the largest increase in LLOS was seen for other liver disease group(14.8 d; 8.1 to 21.5). Patients with cardiovascular disease had 8.5 d(5.7 to 11.3) longer TLOS and 6.0 d(0.2 to 11.9) longer LLOS, compare to those without. Patients with congestive cardiac failure had 7.6 d longer TLOS than those without. Other comorbidities did not significantly increase TLOS nor LLOS.CONCLUSION The time patients spent in hospital varied according to their primary liver disease and some comorbidities. Time spent in hospital of patients with cancer was relatively short compared to most other indications. Cardiovascular disease and congestive cardiac failure were the comorbidities with a strong impact on increased LOS.	Chutwichai Tovikkai Susan C Charman Raaj K Praseedom Alexander E Gimson Jan van der Meulen	2016	World Journal of Transplantation2016，6，4：	0
	12	采用电容电荷转移原理测定含水量	C Gimson 赴敏	1989	现代测量与实验室管理1989，，6：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费